Literature DB >> 20502849

[Interventional procedures for hepatic metastases].

T Helmberger1.   

Abstract

The therapeutic concept for hepatic metastases is mainly based on surgical resection and systemic chemotherapy. Considering technical respectability, oncological significance and limiting comorbidities, only 10-30% of patients with hepatic metastases can undergo surgery with a curative intention. Patients assessed as being non-resectable qualify in general for (palliative) chemotherapy. However, for many patients surgical therapy of the liver is no longer possible due to medical or technical reasons, nevertheless, the total tumor load is still limited, which makes an interventional, local ablative therapy approach promising, with and without chemotherapy. Thus, various interventional-radiological, minimally invasive techniques could be successfully established as oncological therapy components besides surgery and chemotherapy. These types of intervention encompass mainly chemotherapy (percutaneous alcohol instillation, transarterial chemoembolization and transarterial chemotherapy), thermotherapy (radiofrequency, laser and microwave ablations) and radio-ablative procedures (radio-embolization, selective internal radiation therapy SIRT, interstitial and catheter-guided brachytherapy). Incorporating these procedures into therapeutic multimodal concepts inaugurates a significantly broadened therapy spectrum with a clear additional improvement in patient prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502849     DOI: 10.1007/s00104-010-1888-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  64 in total

1.  Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  Surgery       Date:  2006-02       Impact factor: 3.982

2.  Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.

Authors:  Guido Bonomo; Vittorio Pedicini; Lorenzo Monfardini; Paolo Della Vigna; Dario Poretti; Gianluigi Orgera; Franco Orsi
Journal:  Cardiovasc Intervent Radiol       Date:  2009-12-03       Impact factor: 2.740

3.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

4.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Authors:  Hyuk Hur; Yong Taek Ko; Byung Soh Min; Kyung Sik Kim; Jin Sub Choi; Seung Kook Sohn; Chang Hwan Cho; Heung Kyu Ko; Jong Tai Lee; Nam Kyu Kim
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

5.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

Review 6.  Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature.

Authors:  J K Seifert; T Junginger
Journal:  Technol Cancer Res Treat       Date:  2004-04

7.  [Microwave coagulation therapy for liver metastases from colorectal cancer].

Authors:  Tetsushi Morita; Takashi Shibata; Masaki Okuyama; Kimimasa Ikeda; Yasuo Tsukahara; Masashi Kitada; Miki Nishikubo; Tsuyoshi Ishida; Takashi Shimano
Journal:  Gan To Kagaku Ryoho       Date:  2004-05

Review 8.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Authors:  Simone Mocellin; Pierluigi Pilati; Mario Lise; Donato Nitti
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

9.  Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival.

Authors:  Ralf Puls; Soenke Langner; Christian Rosenberg; Katrin Hegenscheid; Jens Peter Kuehn; Kai Noeckler; Norbert Hosten
Journal:  J Vasc Interv Radiol       Date:  2008-12-24       Impact factor: 3.464

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  3 in total

1.  [Laser ablation. Do we still need it?].

Authors:  C Rosenberg; C O M Hoffmann; B Mensel; R Puls; N Hosten
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

2.  Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.

Authors:  Simone Maurea; Pier Paolo Mainenti; Annamaria Tambasco; Massimo Imbriaco; Carmine Mollica; Ettore Laccetti; Luigi Camera; Raffaele Liuzzi; Marco Salvatore
Journal:  Quant Imaging Med Surg       Date:  2014-06

3.  Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival.

Authors:  Philipp Wiggermann; Ralf Puls; Andrej Vasilj; Dominik Sieroń; Andreas G Schreyer; Ernst-Michael Jung; Wojciech Wawrzynek; Christian Stroszczynski
Journal:  Med Sci Monit       Date:  2012-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.